Efficacy of Distant Healing in Glioblastoma Treatment
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study will assess whether distant healing effects survival time and loss of function for glioblastoma patients.
| Condition | Intervention | Phase |
|---|---|---|
|
Glioblastoma |
Procedure: Distant Healing |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Primary Purpose: Treatment |
| Official Title: | Efficacy of Distant Healing in Glioblastoma Treatment |
| Estimated Enrollment: | 150 |
| Study Start Date: | September 2000 |
| Estimated Study Completion Date: | June 2005 |
Prayer, energy healing, and spiritual healing are widely used for all degrees of illness.
Eisenberg (1998) reported that more that 26% of his survey sample used "energy healing" within the last year. Most of these practitioners believe that their inner intentions result in the benefits, either through the agency of love, energy, or a Higher Power (Benor 1992). However, the conventional community attributes benefits from these interventions to the patient's hope, expectation, or experience of support from a practitioner (Benson 1996). The proposed study is a double-blind randomized controlled clinical trial of "distant healing intentionality." Distant Healing (DH) is defined as a "mental intention on behalf of one person, to benefit another at a distance." This study will assess whether DH effects survival time and loss of function for glioblastoma patients under conditions where hope and expectation are controlled. The study will include approximately 150 patients who have rapidly progressing glioblastoma and are beginning radiotherapy. Patients will be photographed and assessed for quality of life, psychological status, and physical symptoms as well as health habits and attitude toward DH. After stratification by age and functional status (Karnofsky score), patients will be randomly assigned to either standard treatment with or without DH. Healers from diverse schools and backgrounds from communities across the United States will be assigned to patients by rotation, so that each patient in the DH group will be treated for two weeks by 10 different healers over the 20 week intervention. Experienced healers will have photographs of subjects and send "mental intention for health and well being" to subjects for one hour daily, three times per week. The healing intervention will be performed at a distance, and patients and healers will never meet, nor will patients know their group assignment. The study findings will provide the basis for developing a larger study, definitive trial.
Eligibility| Ages Eligible for Study: | 18 Years to 75 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion:
- Histologically confirmed diagnosis of glioblastoma based on open resection.
- Patient is within five weeks of diagnosis confirmed by pathology report.
Exclusion:
- Non-English speaking.
- Inability or unwillingness to fill out questionnaires.
- History of other cancers within the last 2 years (except superficial basal cell, squamous cell carcinoma of the skin), or other concurrent life-threatening conditions.
Contacts and Locations| United States, California | |
| California Pacific Medical Center Research Institute | |
| San Francisco, California, United States, 94115 | |
| Principal Investigator: | Andrew Freinkel, MD | California Pacific Medical Center Research Institute |
More Information
Additional Information:
No publications provided
| ClinicalTrials.gov Identifier: | NCT00029783 History of Changes |
| Obsolete Identifiers: | NCT00058500 |
| Other Study ID Numbers: | R01 AT000644-03 |
| Study First Received: | January 23, 2002 |
| Last Updated: | August 17, 2006 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Center for Complementary and Alternative Medicine (NCCAM):
|
Glioblastoma Brain tumor Distant healing Distance healing |
Additional relevant MeSH terms:
|
Glioblastoma Astrocytoma Glioma Neoplasms, Neuroepithelial Neuroectodermal Tumors |
Neoplasms, Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms, Glandular and Epithelial Neoplasms, Nerve Tissue |
ClinicalTrials.gov processed this record on May 23, 2013